Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study

Dellon, 2014, Advances in clinical management of eosinophilic esophagitis, Gastroenterology, 147, 1238, 10.1053/j.gastro.2014.07.055 Furuta, 2007, Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment, Gastroenterology, 133, 1342, 10.1053/j.gastro.2007.08.017 Liacouras, 2011, Eosinophilic esophagitis: updated consensus recommendations for children and adults, J Allergy Clin Immunol, 128, 3, 10.1016/j.jaci.2011.02.040 Dellon, 2013, ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE), Am J Gastroenterol, 108, 679, 10.1038/ajg.2013.71 Safroneeva, 2015, Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity, Aliment Pharmacol Ther, 42, 1000, 10.1111/apt.13370 Hirano, 2013, Editorial: should patients with suspected eosinophilic esophagitis undergo a therapeutic trial of proton pump inhibition?, Am J Gastroenterol, 108, 373, 10.1038/ajg.2012.459 Wolf, 2015, Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis, J Gastroenterol Hepatol Res, 4, 1780, 10.17554/j.issn.2224-3992.2015.04.562 Hirano, 2012, Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?, Clin Gastroenterol Hepatol, 10, 750, 10.1016/j.cgh.2012.02.009 Schoepfer, 2014, Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis, Gastroenterology, 147, 1, 10.1053/j.gastro.2014.08.028 Hirano, 2013, Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system, Gut, 62, 489, 10.1136/gutjnl-2011-301817 Dellon, 2013, Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis, Aliment Pharmacol Ther, 38, 634, 10.1111/apt.12413 Dellon, 2007, Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review, Am J Gastroenterol, 102, 2300, 10.1111/j.1572-0241.2007.01396.x Sperry, 2011, Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE, Am J Gastroenterol, 106, 824, 10.1038/ajg.2011.10 Dellon, 2009, Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease, Clin Gastroenterol Hepatol, 7, 1305, 10.1016/j.cgh.2009.08.030 Dellon, 2012, Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis, Am J Gastroenterol, 107, 1503, 10.1038/ajg.2012.202 Dellon, 2012, Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis, Gastroenterology, 143, 321, 10.1053/j.gastro.2012.04.049 Dellon, 2010, Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial, Gastroenterology, 139, 418, 10.1053/j.gastro.2010.05.001 Konikoff, 2006, A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis, Gastroenterology, 131, 1381, 10.1053/j.gastro.2006.08.033 Alexander, 2012, Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis, Clin Gastroenterol Hepatol, 10, 742, 10.1016/j.cgh.2012.03.018 Gupta, 2015, Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis, Clin Gastroenterol Hepatol, 13, 66, 10.1016/j.cgh.2014.05.021 Wolf, 2014, Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis, Clin Gastroenterol Hepatol, 12, 1272, 10.1016/j.cgh.2013.12.034 Gonsalves, 2012, Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors, Gastroenterology, 142, 1451, 10.1053/j.gastro.2012.03.001 Spergel, 2012, Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet, J Allergy Clin Immunol, 130, 461, 10.1016/j.jaci.2012.05.021 Dellon, 2011, Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia, Dig Dis Sci, 55, 1940, 10.1007/s10620-009-1005-z Reed, 2017, A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis, Aliment Pharmacol Ther, 45, 1443, 10.1111/apt.14061 Dellon, 2016, Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment, Clin Gastroenterol Hepatol, 14, 31, 10.1016/j.cgh.2015.08.040 Vickers, 2001, Statistics notes: analysing controlled trials with baseline and follow up measurements, BMJ, 323, 1123, 10.1136/bmj.323.7321.1123 Pentiuk, 2009, Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis, J Pediatr Gastroenterol Nutr, 48, 152, 10.1097/MPG.0b013e31817f0197 Debrosse, 2011, Long-term outcomes in pediatric-onset esophageal eosinophilia, J Allergy Clin Immunol, 128, 132, 10.1016/j.jaci.2011.05.006 Safroneeva, 2016, Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis, Gastroenterology, 150, 581, 10.1053/j.gastro.2015.11.004 Assa’ad, 2011, An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis, Gastroenterology, 141, 1593, 10.1053/j.gastro.2011.07.044 Wolf, 2015, Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients, Clin Gastroenterol Hepatol, 13, 452, 10.1016/j.cgh.2014.07.034 Dellon, 2014, A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease, Gastrointest Endosc, 79, 577, 10.1016/j.gie.2013.10.027 Dellon, 2017, Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis, Gastroenterology, 152, 776, 10.1053/j.gastro.2016.11.021 Schoepfer, 2013, Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner, Gastroenterology, 145, 1230, 10.1053/j.gastro.2013.08.015 Franciosi, 2011, Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods, BMC Gastroenterol, 11, 126, 10.1186/1471-230X-11-126 Dellon, 2015, Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy, Mod Pathol, 28, 383, 10.1038/modpathol.2014.110